Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 3 × Colitis, Ulcerative × Adalimumab × Clear all

Phase

Phase 3 2 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Spondylitis, Ankylosing 2 Psoriasis 2 Colitis, Ulcerative 2 Plaque Psoriasis 1 Osteoarthritis 1 Hidradenitis Suppurativa 1 Crohn Disease 1 Acne Vulgaris 1 Abscess 1

Interventions

etrolizumab 5 Adalimumab 2 Ringer's Lactate 1 Mesalamine 1 Loperamide 1 Injections 1 Infliximab 1 Hydroxyethyl Starch Derivatives 1 Andrographis paniculata extract 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02163759 2021-07-23

HIBISCUS I

Hoffmann-La Roche

Phase 3 Completed

358 enrolled 42 charts

Colitis, Ulcerative

NCT02171429 2021-07-23

HIBISCUS II

Hoffmann-La Roche

Phase 3 Completed

358 enrolled 38 charts

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡